Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Symbiosis Pharmaceutical Service announced the purchase of new premises in Stirling, Scotland, UK.
read more
Thursday, October 10, 2024
Ingenza, a contract research, development and manufacturing organization (CRDMO) and technology accelerator, announced its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group.
read more
Wednesday, October 09, 2024
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental ...
read more
Wednesday, October 09, 2024
CPHI Milan has announced the winners of the prestigious 2024 CPHI Pharma Awards, celebrating the brightest minds and most innovative advancements across the global pharmaceutical industry.
read more
Wednesday, October 09, 2024
Kindeva Drug Delivery announced two key milestones for its state-of-the-art Bridgeton, MO, facility. The site has successfully completed its first registration batch on its groninger high-volume vial line.
read more
Wednesday, October 09, 2024
Kellie MacLeod has joined Worldwide Clinical Trials as Executive Vice President, Global Quality Assurance, bringing over 23 years of extensive experience in clinical trials, quality assurance, and regulatory affairs. In this role, MacLeod will lead ...
read more
Tuesday, October 08, 2024
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near Manchester, UK.
read more
Tuesday, October 08, 2024
Sterling Pharma Solutions, a contract development and manufacturing organization, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialization of products to treat rare diseases where there is an unmet medical ...
read more
Tuesday, October 08, 2024
Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced a collaboration with Laxxon Medical, a pharma-technology company pioneering a new generation of advanced pharmaceuticals, to provide the ...
read more
Tuesday, October 08, 2024
GBI Biomanufacturing, a Contract Development and Manufacturing Organization (CDMO), and Allterum Therapeutics announced a manufacturing partnership to advance Allterum's lead candidate 4A10 into clinic.
read more
Tuesday, October 08, 2024
Mosaic Therapeutics, Ltd, a targeted oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, today announced the appointment of Dr Barry Davies as CSO, where he will lead the Company’s...
read more
Thursday, October 03, 2024
Ingenza a contract research, development and manufacturing organization (CRDMO) and technology accelerator announced its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group.
read more
Thursday, October 03, 2024
BioDuro-Sundia, a global contract research, development, and manufacturing organization (CRDMO), announced the launch of a new Compound Management Center at its Waigaoqiao site in the Shanghai Free-Trade Zone, China. This new center enables the ...
read more
Wednesday, October 02, 2024
Crown Bioscience, a contract research organization (CRO) headquartered in San Diego, California in the United States, and a part of JSR Life Sciences and JSR Corporation, recently acquired by Japan Investment Corporation Capital Co., Ltd. , today ...
read more
Monday, September 30, 2024
PCI Pharma Services announced it is investing more than $365M in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis ...
read more